- Home
- / Kukje Pharma
Kukje Pharma
Stock Price
₩5.5 K
2024-10-29
Market Capitalization
₩111.4 B
2024-10-29
Revenue
₩175.5 B
FY, 2025
Kukje Pharma Summary
Company Summary
- Overview
- Kukje Pharma is a company that manufactures and sells pharmaceutical products. It offers antidiabetics, adrenal corticosteroids, tetracycline, dermatology agents, antibiotics, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1959
- HQ
- Seongnam-si, KR | view all locations
- Website
- https://www.kukjepharm.co.kr
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Seongnam-si, Gyeonggi-do HQ
Korea (Republic of)
96-8 Yatap-ro, Bundang-gu
Kukje Pharma Financials
Summary Financials
- Revenue (Q1, 2026)
- ₩44.0B
- Gross profit (Q1, 2026)
- ₩24.7B
- Net income (Q1, 2026)
- ₩2.1B
- Cash (Q1, 2026)
- ₩9.1B
- EBIT (Q1, 2026)
- ₩2.2B
- Enterprise value
- $133.2B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026